Cananbidiol (CBD), a non-psychotropic cannabinoid, alleviates psychotic symptoms and may hold promise as an alternative antipsychotic treatment, according to a review published in the November issue of the journal Neuropsychopharmacology. Investigators in the Netherlands and in the United Kingdom reviewed preclinical and clinical data on the use of CBD as […]